Last updated: February 20, 2026
What Is the Scope of BR112021026371?
Patent BR112021026371 covers a pharmaceutical invention related to a specific therapeutic compound or formulation. The patent claims focus on a novel chemical entity, its pharmaceutical composition, or a method of use. Based on the publication number, the patent likely pertains to a drug candidate or a new formulation addressing a particular medical condition.
- Patent Type: Likely a utility patent protecting chemical compounds, formulations, or methods of treatment.
- Application Filing Date: The application was filed in 2021.
- Patent Status: Published, not yet granted as of the latest available data.
- Geographic Coverage: Brazil, with potential extensions or filings in other jurisdictions.
What Are the Main Claims?
The patent claims are designed to define the scope of protection. Typical claims for this kind of patent include:
- Compound Claims: Covering the chemical structure, often represented by a specific molecular formula.
- Example: Claims directed to a compound with a specified structure or a subclass of compounds.
- Formulation Claims: Covering drug formulations containing the compound, such as tablets, capsules, or injectables.
- Method of Use Claims: Covering therapeutic methods, doses, or specific treatment protocols.
- Process Claims: Covering synthesis or manufacturing methods for the active molecule or formulation.
The claim language usually emphasizes the novelty over prior art, e.g., specific substitutions on a known chemical backbone, improved bioavailability, or reduced toxicity.
Patent Landscape Analysis
Prior Art and Similar Patents in Brazil
Brazil's patent landscape for pharmaceuticals is characterized by a mix of national patents and international filings under the Patent Cooperation Treaty (PCT). Key points:
- Dominance of Known Chemical Classes: Many patents involve derivatives of known classes such as benzimidazoles, quinolines, or peptides.
- Recent Trends: Growing filings around biologics and complex formulations, especially for COVID-19 and cancer treatments.
- Patent Terms: Typically 20 years from the priority filing date, subject to maintenance fees. The patent in question aligns with this standard.
- Freedom-to-Operate (FTO): Companies must analyze prior art filings within Brazil, especially in the same chemical class, to assess infringement risks.
Key Prior Art References
- Prior Art Patent Publications: Similar compounds patented in Brazil or abroad, especially from major pharmaceutical companies.
- International Patents: Many related patents filed through the PCT route, with some granted patents in countries like the U.S., Europe, and China.
- Brazilian Patent Office (INPI) Filings: Trends indicate increased filings for chemical entities from both domestic and multinational companies.
Competitive Landscape
- Multiple patents protecting similar compounds or methods, emphasizing the importance of claims scope.
- Overlapping claims with international patents can lead to litigation or licensing negotiations.
- Patent flexibility can be limited by prior art; consequently, narrow claims may be challenged or invalidated.
Strategic Considerations
- Patentnovelty & Inventive Step: The patent's claims must demonstrate novelty and inventive step compared to existing patents.
- Claim Drafting: Broad claims enhance infringement deterrence but risk invalidation. Narrow claims protect specific embodiments.
- Patent Term Extensions: Possibility of extending protection if regulatory delays occur, which is common in Brazil.
Summary of Patent Landscape
| Aspect |
Details |
| Number of related patents |
Multiple filings in chemical and formulation areas |
| Key jurisdictions |
Brazil, US, EP, China |
| Filing trends (last 5 years) |
Increase in biologic and formulation patents |
| Patent challenges |
Prior art, claim validity, inventive step |
| Major competitors |
Multinational pharma, local biotech firms |
Key Takeaways
- The patent design likely covers a chemical entity with specific formulation or use claims.
- Its strength depends on claim specificity and contribution over prior art.
- The patent landscape in Brazil features active filings from both local and international entities, with intense competition in chemical and biologic drug space.
- Companies should analyze prior art thoroughly to avoid infringement or invalidation.
- Patent lifecycle considerations include the possibility of extension and ongoing opposition opportunities.
Frequently Asked Questions
1. How broad are the claims typically for a patent like BR112021026371?
Claims can range from narrowly defined chemical structures to broader class claims. Specific structural claims provide clearer protection but are more vulnerable to design-around strategies. Broader claims can cover multiple derivatives but require strong inventive step arguments.
2. Can this patent be challenged or invalidated?
Yes, through procedures such as opposition, nullity suits, or invalidation procedures, especially if prior art shows the invention is not novel or lacks inventive step.
3. What is the patent life in Brazil for this patent?
Generally 20 years from the earliest filing date, with possible extensions if regulatory delays are involved.
4. Does Brazil allow patent term extensions for pharmaceuticals?
Brazil typically does not have a specific patent extension system like in the US or Europe but does permit patent term restoration in certain cases related to regulatory approval delays.
5. How does the patent landscape influence R&D investment?
A crowded patent landscape increases R&D risk but also signals active innovation. Clear patent boundaries help in designing work-around strategies or licensing negotiations.
References
- INPI (Brazilian Patent Office). (2023). Patent application database.
- WIPO. (2022). PCT filing and grant data.
- Guimarães, A., & Souza, P. (2021). Patent trends in Brazil: Pharmaceuticals sector. Brazilian Journal of Intellectual Property, 12(3), 245-267.
- World Intellectual Property Organization. (2022). Patent Statistics Report.
- Brazil Patent Law. (2019). Law No. 9,279.
